Skip to content
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Contact Us
Schwab Client Login
Recent Quotes
View Full List
My Watchlist
Crombie REIT
Foremost Lithium Resource & Technology Ltd
LifeStance Health Group, Inc. - Common Stock
Nxt Energy Solutions Inc
Solid Biosciences Inc. - Common Stock
micromobility.com Inc. - Class A Common Stock
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Mirati Therapeutics, Inc. - Common Stock
(NQ:
MRTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
58.85 (1)
Ask (Size)
59.74 (10)
Prev. Close
58.70
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
51,623,193
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
↗
December 29, 2023
According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.
Via
Benzinga
EnerSys To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
↗
December 20, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Performance
More News
Read More
Analyst Expectations For Mirati Therapeutics's Future
↗
December 20, 2023
Via
Benzinga
Improving Survival Rates: Biotech Innovations in Pancreatic Cancer Treatment
November 29, 2023
Via
FinancialNewsMedia
Topics
Death
What 11 Analyst Ratings Have To Say About Mirati Therapeutics
↗
November 07, 2023
Via
Benzinga
3 Resilient Stocks with Massive Potential to Boost Your Wealth
↗
November 26, 2023
Via
InvestorPlace
These Three Biotech Stocks Are Trading At A Discount
↗
November 23, 2023
Via
Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
↗
November 17, 2023
Via
Benzinga
3 Biotech Stocks That Could Boom or Bust by 2025
↗
November 16, 2023
Via
InvestorPlace
MIRATI THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mirati Therapeutics, Inc. - MRTX
November 08, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
3 No-Brainer Stocks to Buy With $500 Right Now
↗
November 08, 2023
Via
The Motley Fool
Appian To Rally Around 47%? Here Are 10 Top Analyst Forecasts For Tuesday
↗
November 07, 2023
Via
Benzinga
Is MIRATI THERAPEUTICS INC Ready to Break Out of Its Range?
↗
November 06, 2023
Via
Chartmill
7 Healthcare Stocks That Can Cure a Lackluster Portfolio
↗
October 19, 2023
Via
InvestorPlace
Opdivo's Subcutaneous Formulation Shows Promise in Advanced Kidney Cancer: Bristol Myers Squibb's Latest Findings
↗
October 19, 2023
Via
Benzinga
Bristol Myers Squibb Enters the Multi-Billion-Dollar Oncology Race
October 17, 2023
Via
PressReach
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Consolidated Communications Holdings, Inc. (Nasdaq – CNSL), Mirati Therapeutics, Inc.® (Nasdaq - MRTX), Pioneer Natural Resources (NYSE - PXD), Summit Materials (NYSE
October 16, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Amgen Stock Surges To 10-Month High, Up 4% On An Unexpected Upgrade
↗
October 11, 2023
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023
↗
October 10, 2023
Via
Benzinga
Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race
October 10, 2023
Via
PressReach
MIRATI THERAPEUTICS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mirati Therapeutics, Inc. - MRTX
October 09, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
↗
October 09, 2023
Via
Benzinga
Why Shares of Tango Therapeutics Are Dropping Monday
↗
October 09, 2023
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 9, 2023
↗
October 09, 2023
Via
Benzinga
Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
October 09, 2023
Via
Benzinga
Frequently Asked Questions
Is Mirati Therapeutics, Inc. - Common Stock publicly traded?
Yes, Mirati Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Mirati Therapeutics, Inc. - Common Stock trade on?
Mirati Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Mirati Therapeutics, Inc. - Common Stock?
The ticker symbol for Mirati Therapeutics, Inc. - Common Stock is MRTX on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
